Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

1α,25-Dihydroxyvitamin D₃ inhibits the human H295R cell proliferation by cell cycle arrest: a model for a protective role of vitamin D receptor against adrenocortical cancer.

Pilon C, Urbanet R, Williams TA, Maekawa T, Vettore S, Sirianni R, Pezzi V, Mulatero P, Fassina A, Sasano H, Fallo F.

J Steroid Biochem Mol Biol. 2014 Mar;140:26-33. doi: 10.1016/j.jsbmb.2013.11.008. Epub 2013 Nov 20.

PMID:
24269839
[PubMed - indexed for MEDLINE]
2.

MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.

Chiang KC, Yeh CN, Hsu JT, Chen LW, Kuo SF, Sun CC, Huang CC, Pang JH, Flanagan JN, Takano M, Kittaka A, Juang HH, Yang SW, Chen TC.

J Steroid Biochem Mol Biol. 2013 Nov;138:427-34. doi: 10.1016/j.jsbmb.2013.09.002. Epub 2013 Sep 14.

PMID:
24044969
[PubMed - indexed for MEDLINE]
3.

Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice.

Boyan BD, Sylvia VL, McKinney N, Schwartz Z.

J Cell Biochem. 2003 Dec 15;90(6):1207-23.

PMID:
14635194
[PubMed - indexed for MEDLINE]
4.

1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.

Nakagawa K, Kawaura A, Kato S, Takeda E, Okano T.

Carcinogenesis. 2005 Feb;26(2):429-40. Epub 2004 Nov 11.

PMID:
15539405
[PubMed - indexed for MEDLINE]
Free Article
5.

The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion.

Tetlow LC, Woolley DE.

Arthritis Res. 1999;1(1):63-70. Epub 1999 Oct 14.

PMID:
11056661
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.

Harant H, Spinner D, Reddy GS, Lindley IJ.

J Cell Biochem. 2000 Apr;78(1):112-20.

PMID:
10797570
[PubMed - indexed for MEDLINE]
7.

The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.

Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, Carlberg C.

J Mol Biol. 2005 Jun 3;349(2):248-60. Epub 2005 Apr 7.

PMID:
15890193
[PubMed - indexed for MEDLINE]
8.

Short-chain fatty acids and colon cancer cells: the vitamin D receptor--butyrate connection.

Gaschott T, Stein J.

Recent Results Cancer Res. 2003;164:247-57.

PMID:
12899527
[PubMed - indexed for MEDLINE]
9.

The effects of 1alpha,24(S)-dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression.

Shany S, Levy Y, Lahav-Cohen M.

Steroids. 2001 Mar-May;66(3-5):319-25.

PMID:
11179740
[PubMed - indexed for MEDLINE]
10.
11.

1α,25-Dihydroxyvitamin D3 exerts tissue-specific effects on estrogen and androgen metabolism.

Lundqvist J, Norlin M, Wikvall K.

Biochim Biophys Acta. 2011 Apr;1811(4):263-70. doi: 10.1016/j.bbalip.2011.01.004. Epub 2011 Jan 22.

PMID:
21262387
[PubMed - indexed for MEDLINE]
Free Article
13.

New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase.

Bini F, Frati A, Garcia-Gil M, Battistini C, Granado M, Martinesi M, Mainardi M, Vannini E, Luzzati F, Caleo M, Peretto P, Gomez-Muñoz A, Meacci E.

Neuropharmacology. 2012 Sep;63(4):524-37. doi: 10.1016/j.neuropharm.2012.04.026. Epub 2012 May 8.

PMID:
22579669
[PubMed - indexed for MEDLINE]
14.

Sensitivity to growth suppression by 1alpha,25-dihydroxyvitamin D(3) among MCF-7 clones correlates with Vitamin D receptor protein induction.

Jensen SS, Madsen MW, Lukas J, Bartek J, Binderup L.

J Steroid Biochem Mol Biol. 2002 Jun;81(2):123-33.

PMID:
12137801
[PubMed - indexed for MEDLINE]
15.

Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.

Seuter S, Pehkonen P, Heikkinen S, Carlberg C.

Biochim Biophys Acta. 2013 Dec;1829(12):1266-75. doi: 10.1016/j.bbagrm.2013.10.003. Epub 2013 Nov 1.

PMID:
24185200
[PubMed - indexed for MEDLINE]
16.

Characterization of vitamin D receptor (VDR) in lung adenocarcinoma.

Kim SH, Chen G, King AN, Jeon CK, Christensen PJ, Zhao L, Simpson RU, Thomas DG, Giordano TJ, Brenner DE, Hollis B, Beer DG, Ramnath N.

Lung Cancer. 2012 Aug;77(2):265-71. doi: 10.1016/j.lungcan.2012.04.010. Epub 2012 May 6.

PMID:
22564539
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effect of 20-epi-1alpha,25-dihydroxyvitamin D3 on the proliferation of human neuroblastoma: role of cell cycle regulators and the Myc-Id2 pathway.

Gumireddy K, Ikegaki N, Phillips PC, Sutton LN, Reddy CD.

Biochem Pharmacol. 2003 Jun 15;65(12):1943-55.

PMID:
12787874
[PubMed - indexed for MEDLINE]
18.

The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.

Eelen G, Verlinden L, van Camp M, van Hummelen P, Marchal K, de Moor B, Mathieu C, Carmeliet G, Bouillon R, Verstuyf A.

J Bone Miner Res. 2004 Jan;19(1):133-46.

PMID:
14753745
[PubMed - indexed for MEDLINE]
19.

A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth.

Lambert JR, Eddy VJ, Young CD, Persons KS, Sarkar S, Kelly JA, Genova E, Lucia MS, Faller DV, Ray R.

Cancer Prev Res (Phila). 2010 Dec;3(12):1596-607. doi: 10.1158/1940-6207.CAPR-10-0122.

PMID:
21149334
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Vitamin D and systemic cancer: is this relevant to malignant melanoma?

Osborne JE, Hutchinson PE.

Br J Dermatol. 2002 Aug;147(2):197-213. Review.

PMID:
12174089
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk